Trial Profile
Phase II Non Comparative, Open Study to Assess the Efficacy and Safety of the Botulinum Toxin Type A in Patients With Restless Legs Syndrome (RLS).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Oct 2013
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Restless legs syndrome
- Focus Therapeutic Use
- Acronyms SOXIS
- 18 Jul 2012 Actual end date (Nov 2011) added as reported by ClinicalTrials.gov.
- 23 Nov 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 01 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.